47 results on '"Stuckey, Ruth"'
Search Results
2. Prediction of major bleeding events in 1381 patients with essential thrombocythemia
3. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
4. Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission
5. Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes
6. The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia
7. Biomarkers of Response to Venetoclax Therapy in Acute Myeloid Leukemia
8. DNMT3A/TET2/ASXL1 mutations are an age-independent thrombotic risk factor in polycythemia vera patients: an observational study
9. Acute neurologic deterioration in a patient with asymptomatic Charcot-Marie-Tooth disease following three doses of Brentuximab-Vedotin.
10. Phenotypic Anchoring of Gene Expression Changes during Estrogen-Induced Uterine Growth
11. DNMT3A/TET2/ASXL1 mutations are an age-independent thrombotic risk factor in polycythemia vera patients: an observational study
12. Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms
13. PB1893: CLONAL EVOLUTION WITH BCL-2 AMPLIFICATION DURING VENETOCLAX TREATMENT
14. PB1779: FLT3-ITD MUTATION CHARACTERIZATION WITH CLASSICAL PCR METHODOLOGY VERSUS CAPTURE- AND AMPLICON-BASED NGS PLATFORMS: A PETHEMA NGS-AML PROJECT
15. PB1754: HOMOZYGOUS DELETION OF ETV6: EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OR PRECURSOR T-LYMPHOBLASTIC LYMPHOMA
16. Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment
17. Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma
18. Role for RNA : DNA hybrids in origin-independent replication priming in a eukaryotic system
19. Coexisting Myeloproliferative and Lymphoproliferative Neoplasms: A European Multicenter Retrospective Study
20. Cauda equina syndrome secondary to extramedullary erythropoiesis in a transfusion‐dependent thalassemia patient following treatment with luspatercept: A case report
21. Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study
22. Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages
23. Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology
24. Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology
25. Can the Gene Expression Profile of Patients with Acute Myeloid Leukemia Predict Complete Remission Following Induction Therapy?
26. Clinical Impact of Copy Number Variation Revealed By Next Generation Sequencing in Acute Myeloid Leukemia
27. Quantification of JAK2 V167F in Patients with Myeloproliferative Neoplasms: Comparison of NGS and Digital PCR with Quantitative PCR
28. Biological Factors Associated with Treatment-Free Remission in Clinical Practice: Data from the Canarian Registry of CML
29. Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera
30. Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation
31. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study
32. Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
33. BCL2 Expression at Post-Induction and Complete Remission Impact Outcome in Acute Myeloid Leukemia
34. Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations
35. Secondary hemosiderosis presented by porphyria cutanea tarda in a kidney dialysis patient: A case report
36. High factor VIII levels and arterial thrombosis: illustrative case and literature review
37. The experience of seeking, gaining and maintaining employment after traumatic spinal cord injury and the vocational pathways involved.
38. The experience of seeking, gaining and maintaining employment after traumatic spinal cord injury and the vocational pathways involved
39. Telemedicine is helping the parents of children with neurodevelopmental disorders living in remote and deprived areas
40. Studies on the effects of persistent RNA priming on DNA replication and genomic stability
41. Role for RNA: DNA hybrids in origin-independent replication priming in a eukaryotic system
42. Role for RNA:DNA hybrids in origin-independent replication priming in a eukaryotic system
43. Studies on the effects of persistent RNA priming on DNA replication and genomic stability.
44. Quantification of JAK2V167F in Patients with Myeloproliferative Neoplasms: Comparison of NGS and Digital PCR with Quantitative PCR
45. Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia.
46. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.
47. Physician expelled from Indian Association of Occupational Health after critique.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.